KYLE PISKEL - 28 Oct 2021 Form 3 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Principal Accounting Officer
Signature
/s/ Kyle Piskel by Eric Billings, Attorney in Fact
Issuer symbol
ADPT
Transactions as of
28 Oct 2021
Transactions value $
$0
Form type
3
Filing time
03 Nov 2021, 21:00:26 UTC
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADPT Common Stock 2,862 28 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 2,500 $6.32 Direct F1
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 11,980 $6.55 Direct F2
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 3,750 $7.8 Direct F3
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 4,900 $27.29 Direct F4
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 13,474 $28.32 Direct F5
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 15,000 $45.82 Direct F6
holding ADPT Stock Option (Right to Buy) 28 Oct 2021 Common Stock 7,154 $43.68 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested.
F2 The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options vested with respect to 1/4 of such shares on October 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5 The options vested with respect to 1/4 of such shares on February 27, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6 The options vested with respect to 1/4 of such shares on September 24, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F7 The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Remarks:

Mr. Piskel was designated Principal Accounting Officer on October 28, 2021.